Treatment outcomes of extensively drug-resistant tuberculosis in Europe: a retrospective cohort study.

Kherabi Y, Skouvig Pedersen O, Lange C, Bénézit F, Chesov D, Codecasa LR, Dudnyk A, Kiria N, Konstantynovska O, Marigot-Outtandy D, Panciu TC, Poignon C, Sasi S, Schaub D, Solodovnikova V, Vasiliauskaitè L, Yeghiazaryan L, Günther G, Guglielmetti L, TBnet/ESGMYC XDR-TB Study Group

Open source

DOI: 10.1016/j.lanepe.2025.101380
Published: 2025 Sep
Container: The Lancet regional health. Europe
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.lanepe.2025.101380,
  title = {Treatment outcomes of extensively drug-resistant tuberculosis in Europe: a retrospective cohort study.},
  author = {Kherabi Y and Skouvig Pedersen O and Lange C and Bénézit F and Chesov D and Codecasa LR and Dudnyk A and Kiria N and Konstantynovska O and Marigot-Outtandy D and Panciu TC and Poignon C and Sasi S and Schaub D and Solodovnikova V and Vasiliauskaitè L and Yeghiazaryan L and Günther G and Guglielmetti L and TBnet/ESGMYC XDR-TB Study Group},
  year = {2025},
  journal = {The Lancet regional health. Europe},
  doi = {10.1016/j.lanepe.2025.101380},
  url = {https://doi.org/10.1016/j.lanepe.2025.101380}
}

RIS

TY  - JOUR
TI  - Treatment outcomes of extensively drug-resistant tuberculosis in Europe: a retrospective cohort study.
AU  - Kherabi Y
AU  - Skouvig Pedersen O
AU  - Lange C
AU  - Bénézit F
AU  - Chesov D
AU  - Codecasa LR
AU  - Dudnyk A
AU  - Kiria N
AU  - Konstantynovska O
AU  - Marigot-Outtandy D
AU  - Panciu TC
AU  - Poignon C
AU  - Sasi S
AU  - Schaub D
AU  - Solodovnikova V
AU  - Vasiliauskaitè L
AU  - Yeghiazaryan L
AU  - Günther G
AU  - Guglielmetti L
AU  - TBnet/ESGMYC XDR-TB Study Group
PY  - 2025
JO  - The Lancet regional health. Europe
DO  - 10.1016/j.lanepe.2025.101380
UR  - https://doi.org/10.1016/j.lanepe.2025.101380
ER  -

APA

Y, K., O, S. P., C, L., F, B., D, C., LR, C., A, D., N, K., O, K., D, M., TC, P., C, P., S, S., D, S., V, S., L, V., L, Y., G, G., L, G., & Group, T. X. S. (2025). Treatment outcomes of extensively drug-resistant tuberculosis in Europe: a retrospective cohort study.. The Lancet regional health. Europe. https://doi.org/10.1016/j.lanepe.2025.101380

Source records

pubmed · retrieved 2026-09-26T10:19:13.674Z